Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT02478294
Eligibility Criteria:
Inclusion Criteria:
* 18-80 years
* Have documented AF episodes
* The occurrence of ischemic stroke, TIA or systemic thromboembolism at least one month before enrollment
* Capable of understanding and signing the CRF
Exclusion Criteria:
* Reversible AF
* Modified Rankin score ≥4
* Having a history of rheumatic, severe valvular heart disease or heart valve replacement
* Having symptomatic carotid artery disease
* Having another disease which requires lifelong warfarin therapy
* Medical conditions limiting expected survival to \<1 year
* Women of childbearing potential (unless post-menopausal or surgically sterile)
* Participation in any other clinical mortality trial
* Unable to give informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02478294
Study Brief:
Protocol Section:
NCT02478294